CancerBiology&Therapy《癌症生物学与治疗》投稿须知（官网信息）

417 226

OpenAccessmeansyoucanpublishyourresearchsoitisfreetoaccessonlineassoonasitispublished,meaninganyonecanread(andcite)yourwork.PleaseseeourguidetoOpenAccessformoreinformation.Manyfundersmandatepublishingyourresearchopenaccess;youcancheckopenaccessfunderpoliciesandmandateshere.

PleasenotethatthisjournalonlypublishesmanuscriptsinEnglish.

CancerBiology&Therapyacceptsthefollowingtypesofarticle:

LettertotheEditor

Review

MeetingReports

Perspectives

Bedside-to-BenchReports

ResearchPapers

ArticlePublishingCharge

ForpaperssubmittedonorafterSeptember21,2021,thestandardarticlepublishingcharge(APC)forthisjournalis$2800USD,￡2155GBP,€2475EUR,AU$3750forresearcharticlesand$1400USDforJournalClubreportsandMeetingReports,plusVATorotherlocaltaxeswhereapplicableinyourcountry.Thereisnosubmissioncharge.

Findoutmoreaboutarticlepublishingchargesandfundingoptions.

ForpaperssubmittedpriortoSeptember21,2021,publicationcostformswillbeprovidedtothecorrespondingauthorattheproofsstage.Thecompletedformmustbereturnedwithin7businessdays.FailuretoreturnacompletedformwillresultindelayedfinalpublicationoftheVersionofRecord.

StandardpagechargestopublishinCancerBiology&Therapyandoptionalprintcolorartchargesappearbelow:

ResearchPaper:$110/page

BriefReport:$110/page

Review:$110/page

Commentary:$110/page

SupplementaryFiles:$110/totaltext,figures,tables

SupplementaryMovies:$163/firstmovie+$56/subsequentmoviefiles

PrintColorArt

1stpage:$375

Additionalpages:$163/page(nolimit)

OpenAccess

ResearchPaper:$2500

BriefReport:$1650

Review:$1650

JournalClub:$1250

MeetingReport:$1650

BriefCommunication:$1650

BedsidetoBenchReport:$2500

ClinicalCaseReport:$2500

ClinicalStudy:$2500

Commentary:$1250

PreparingYourPaper

Allauthorssubmittingtomedicine,biomedicine,healthsciences,andalliedandpublichealthjournalsshouldconformtotheUniformRequirementsforManuscriptsSubmittedtoBiomedicalJournals,preparedbytheInternationalCommitteeofMedicalJournalEditors(ICMJE).

LetterstotheEditor

Shouldcontainastructuredabstractof150words.

Shouldcontainbetween5and10keywords.Readmakingyourarticlemorediscoverable,includinginformationonchoosingatitleandsearchengineoptimization.

Reviewsshouldberecognizedasscholarlybyspecialistsinthefieldbeingcovered,butshouldalsobewrittenwithaviewtoinformingreaderswhoarenotspecializedinthatparticularfield,andshouldthereforebepresentedusingsimpleprose.Pleaseavoidexcessivejargonandtechnicaldetail.Reviewsshouldcapturethebroaddevelopmentsandimplicationsofrecentwork.Theopeningparagraphshouldmakeclearthegeneralthrustofthereviewandprovideaclearsenseofwhythereviewisnowparticularlyappropriate.Theconcludingparagraphshouldprovidethereaderwithanideaofhowthefieldmaydeveloporfutureproblemstoovercome,butshouldnotsummarizethearticle.Toensurethatareviewislikelytobeaccessibletoasmanyreadersaspossible,itmaybeusefultoaskacolleaguefromanotherdisciplinetoreadthereviewbeforesubmittingit.Submittedreviewsaresubjecttothesamepagechargesasfull-lengthreports—whetherpagechargesapplyforcommissionedreviewswillbedetermineduponeachcommission.Reviewsshouldcitenomorethan150references.

MeetingReportsaresummariesofpresentationsfromrecentmeetingsinthefield.AuthorsareencouragedtocontacttheEditor-in-Chiefwithproposalsformeetingreports.Also,pleasecontactthemeetingorganizerstoverifythatreportswillbepermitted.

THE END

中华医学杂志社公司官网

我院英文期刊CancerBiologyMedicine最新影响因子公布（IF=4.467）！天津市肿瘤医院

CancerBiologyMedicine

CancerBiology&Therapy《癌症生物学与治疗》投稿须知（官网信息）

1.News${page.brandSlug}Stanford Cancer Institute members Allison Kurian, MD, MSc and Jennifer Caswell-Jin, MD, received a $3.5 million legacy gift to launch the Bright Pink Preventive Risk Outreach And Cascade Testing Program. 1 of 5 More Stanford Cancer Institute news More Stanford Medicine News cancer news Morehttps://med.stanford.edu/cancer/about/news.html
2.SearchCenterforCancerResearchStaff Scientist - Cryo-EM, Centrosome biology, Microscopy Date Posted Dec 20, 2024 Job Location Frederick Degree Required Biologist - Neurodevelopmental disorders, cancer Date Posted Nov 8, 2024 Job Location Bethesda Degree Required B.S./B.A. or equivalent https://ccr.cancer.gov/careers/search
3.学术成果Biomaterials丨Ben Wang: Cell calcification reverses the chemoresistance of cancer cells via the conversionInstitute of Translational Medicine, Zhejiang University Address: 268 Kaixuan Road, Shangcheng http://itm.zju.edu.cn/en/achievements.html
4.CancerDefinition,Causes,Types,&TreatmentBritannicaIn addition, laboratory investigations aimed at understanding the causes and mechanisms of cancer have maintained optimism that the disease can be controlled. Through breakthroughs in cell biology, genetics, and biotechnology, researchers have gained a fundamental understanding of what occurs within cells http://www.britannica.com/science/cancer-disease
5.转化医学网4666内容 0关注 4835粉丝 转化医学核心门户 上海 更多信息 独特免疫景观!苏州大学陈卫昌教授团队:新的胃癌生物标志物 2024-12-22 14:25 【Nature子刊】卵巢癌药物敏感性提升:中南大学彭淑平团队发现关键分子机制 2024-12-22 14:24 直播倒计时1天 | ASO在功能基因组研究中的应用进展线上研讨会 https://www.163.com/dy/media/T1608556126673.html
6.FusionGDBAnimal Database category: Gene genome and annotationGenotype phenotype and variation Major species: Homo sapiens Keywords: Pan-cancerfusion gene Contact information University/Institution:University of Texas Health Science Center at Houston Address:Center for Computational Systems Medicine School of Biomedicalhttps://bigd.big.ac.cn/databasecommons/database/id/6154
7.中国临床试验注册中心This will help clarify the role of enteral immune nutrients in anti-inflammatory and immune regulatory functions during concurrent chemoradiotherapy for cervical cancer. 药物成份或治疗方案详述: Description for medicine or protocol of treatment in detail: 纳入标准: (1)患者完全自愿且有自主能力,在https://www.chictr.org.cn/showproj.html?proj=251669
8.MedscapeRegistrationCommenting on the findings forMedscape Medical News, Emerson Wickwire, PhD, who heads a Sleep Medicine Unit at the University of Maryland School of Medicine, Baltimore, noted that insomnia “is the most common sleep disorder seen in clinical practice,” adding that there’s “a dramatic unmet http://www.medscape.com/viewarticle/vagus-nerve-stimulation-safe-effective-chronic-insomnia-2024a1000nf2
9.NewsClinicalOncologyNews&InsightsOncLiveOncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Oncology Business Management Pediatric Oncology Precision Medicine in Oncology? Sarcomas Supportive Care Spotlight - In-person and virtual events just for https://www.onclive.com/view
10.17本高质量肿瘤期刊影响因子及官网汇总前沿热点速查!https://aacrjournals.org/cancerres 14 Oncogene SCI分区:Q1。IF: 8.756。 Nature子刊。侧重于肿瘤发生发展及耐药机制、肿瘤细胞和分子生物学等领域的创新研究。 https://www.nature.com/onc/ 15 Cancer Biology & Medicine SCI分区:Q2。IF: 5.347。 中国抗癌协会与天津医科大学肿瘤医院共同主办。侧重于肿瘤的生物https://www.360doc.cn/article/79947906_1065667236.html
11.tumorLeadersinPharmaceuticalBusinessIntelligenceGroupPosted inCANCER BIOLOGY & Innovations in Cancer Therapy,Personalized and Precision Medicine & Genomic Research,Pharmaceutical Analytics,Pharmaceutical Industry Competitive Intelligence,Pharmaceutical R&D Investment,Pharmacogenomics,Population Health Management, Genetics & Pharmaceutical, taggedAileron Therapeutics,Aviva https://pharmaceuticalintelligence.com/tag/tumor/
12.CANCERBIOLOGY&MEDICINE(癌症生物学与医学)订阅网国内外报纸(已被浏览1674次) 出版周期: 月刊 单价:￥100.00 主办单位: 中国抗癌协会 编辑出版: 中国肿瘤临床英文版编辑部 订阅选择 订期市场价订阅价折扣 全年订￥1204.00￥1204.00无 商品描述 主要栏目 版权信息 国际标准刊号: 国内统一刊号: CN12-1431/R 邮发代号: 6-173 http://edingyue.com/sub/user/doviewproduct.action?id=217704
13.2024年12月19日《新英格兰医学杂志》英文音频和中英文摘要英文音频来自NEJM官网nejm.org 1 ponsegromab治疗癌性恶病质 Ponsegromab for the Treatment of Cancer Cachexia 摘要 背景 恶病质是癌症的常见并发症,与死亡风险增加相关。生长分化因子15(GDF-15)是一种循环细胞因子。癌性恶病质患者的GDhttps://mp.weixin.qq.com/s?__biz=MzIxNTc4NzU0MQ==&mid=2247550035&idx=2&sn=5205caa70f762e1a4e8dad8039ac6ca6&chksm=96feb8a819b8750fc2196c2d11b29b024bc4c58b4e6c2d38cd2ba58cdd5fc2b552aaa2c9ae73&scene=27
14.CancerBiology&Medicine投稿官网一审周期多长时间通过对比Cancer Biology & Medicine投稿官网、一审周期多长时间影响因子分值、sitescore值、审稿周期、投稿录用率等指标,以图表的形式直观展现Cancer Biology & Medicine投稿官网、一审周期多长时间各个指标的对比趋势图,让您一目了然的看到各个期刊的优缺点,快速锁定目标期刊进行投稿,节省投稿周期! Cancerhttps://www.360qikan.com/sciduibi/68766.html
15.CancerBiology&MedicineCancer Biology & Medicine,Cancer Biology,Medicine,The Official Journal of The China Anti-Cancer AssociationCancer BiologyMedicine is a peer-reviewed open-access journal shttps://wap.cnki.net/touch/web/Journal/Article/CJCO201704001.html
16.《中国肿瘤临床》第五届与CancerBiology&Medicine第三届编委为系统总结《中国肿瘤临床》与Cancer Biology & Medicine(CBM)的工作,科学谋划未来五年的发展,恰逢天津医科大学肿瘤医院建院160年院庆之际,《中国肿瘤临床》第五届与CBM第三届编委会成立大会暨2021年编委工作会议于2021年12月10日在天津宾馆顺利召开。 中国工程院院士、国家恶性肿瘤临床医学研究中心主任、天津市肿瘤研究http://www.tjtaca.com/search/detail/id/248.shtml
17.高质量科技期刊分级目录总汇(2022年12月)Nature Reviews Cancer 中华肿瘤杂志 Nature Reviews Clinical Oncology Chinese Journal of Cancer Research Annals of Oncology Cancer Biololgy & Medicine JAMA Oncology Cancer Communications (former title: Chinese Journal of Cancer) Cancer Research T2 Seminars in Cancer Biology Cancer Immunology Researchhttps://www.scholat.com/teamwork/teamwork/showPostMessage.html?id=12873
18.CancerBiology&Medicine杂志Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer michttps://www.youfabiao.com/sci/20953941/
19.CancerBiology&Medicine期刊介绍CANCER BIOL MED/Cancer Biology & Medicine ISSN 2095-3941 影响指数话题 影响指数话题 预警等级 MedSci期刊指数 7.45 (MedSci实时期刊指数) | 10.8995 (5年期刊指数) CiteScore值 0.0 h-index 42 h5-median 暂无数据 出版社/管理机构 杂志由 Chinese Anticancer Association 出版或管理 出版国家/地https://www.medsci.cn/sci/journal.do?id=f67913106
20.CancerBiology&Medicine好投吗到2023年发文量为91篇,国人文章为85篇,占比为93.4%,国人投稿难度偏小。 总的来说,Cancer Biology & Medicine在领域中影响力和排名适中,影响因子为5.9,年发文量为43篇,审稿速度平均12周,2023年国人文章占比93.4%,投稿难度属于较低级别。 时间急,投稿总被拒?https://www.peipusci.com/news/15793.html
21.cancerbiology&medicine期刊的影响因子JCR分区中科院分区基本信息 期刊全称 cancer biology & medicine 期刊简称 Print ISSN 2095-3941 Online ISSN nan 期刊出版社 是否开放获取 Open Access,OA 是 官网地址 期刊所属领域 期刊简介 JCR分区索引信息2021年数据 是否是SCIE(SCI) 注:SCI已经完全被SCIE取代,参考:SCI被取代 https://www.datalearner.com/academic/journal/detail/2095-3941
22.CancerBiology&Medicine这本曾在国内排名第一的肿瘤学期刊,几Cancer Biology & Medicine的最新影响因子(JCR 2020)为5.347,在JCR医学研究与实验类(52/139)及肿瘤学类(85/245)中均处Q2区。中科院分区大类医学2区,小类医学研究与实验类3区,肿瘤学3区。 审稿周期 期刊官网对于审稿时间并没有标识,但是我们通过随机查阅最新发布的几篇文章数据可以看到,从投稿到接受最快https://scipaperpub.com/cancer-biology-medicine-%E8%BF%99%E6%9C%AC%E6%9B%BE%E5%9C%A8%E5%9B%BD%E5%86%85%E6%8E%92%E5%90%8D%E7%AC%AC%E4%B8%80%E7%9A%84%E8%82%BF%E7%98%A4%E5%AD%A6%E6%9C%9F%E5%88%8A%EF%BC%8C%E5%87%A0%E7%BB%8F/
23.cancerbiology&medicine期刊简称:CANCER BIOL MED 期刊全称:Cancer Biology & Medicine ISSN2095-3941 影响因子2022:5.6 (2023年7月5日更新) 学科分类:SCIE-(医学研究与实验)-MEDICINE, RESEARCH & EXPERIMENTAL SCIE-(肿瘤学)-ONCOLOGY 出版商:CHINA ANTI-CANCER ASSOC 发行地址:TIANJIN MEDICAL UNIV, CANCER INST & HOSPITAL TI-YUAN-http://impactfactor.cn/4663.html
24.InterpretingpathwaystodiscovercancerdrivergeneswithCancer driver gene alterations influence cancer development, occurring in oncogenes, tumor suppressors, and dual role genes. Discovering dual role cancer genes is difficult because of their elusive context-dependent behavior. We define oncogenic mediators as genes controlling biological processes. With themhttps://www.nature.com/articles/s41467-019-13803-0
25.DEEPLEARNINGMETHODSFORDRUGRESPONSEPREDICTIONINCANCERThe algorithms for processing the raw data evolve as well, thereby providing more reliable representations of the underlying cancer biology and allowing projects to update their repositories with refined versions of existing data while utilizing improved processing techniques (e.g., DepMap portal [65])http://arxiv.org/pdf/2211.10442v1
26.CANCERBIOLOGY&MEDICINE(癌症生物学与医学)订阅网国内外报纸(已被浏览1675次) 出版周期: 月刊 单价:￥100.00 主办单位: 中国抗癌协会 编辑出版: 中国肿瘤临床英文版编辑部 订阅选择 订期市场价订阅价折扣 全年订￥1204.00￥1204.00无 商品描述 主要栏目 版权信息 国际标准刊号: 国内统一刊号: CN12-1431/R 邮发代号: 6-173 http://www.edingyue.cn/sub/user/doviewproduct.action?id=217704